directorsblog.nih.gov
KRAS Targeted Cancer Strategy Shows Early Promise
Of the more than 1.7 million Americans expected to be diagnosed with cancer this year, nearly one-third will have tumors that contain at least one mutation in the RAS family of genes [1]. That incl…